Somatix Appoints Technology Veteran Dr. Amit Sawant as Its First Chief Business Development Officer
NEW YORK, May 18, 2021 /PRNewswire/ -- Somatix, a provider of a wearable-assisted, gesture detection RPM (Remote Patient Monitoring) platform has named Amit Sawant, Ph.D., M.B.A., as its first Chief Business Development Officer, an appointment that will further accelerate Somatix's growth and sales in the remote patient monitoring market. Dr. Sawant is a proven customer-centric leader with extensive experience in enterprise and consumer space, SaaS, analytics, AI/ML, and security. He has an exceptional ability of translating concepts into reality through thought leadership, collaboration, and negotiation skills.
Dr. Sawant previously was the Director of Product Management at Dell Technologies for Data Protection products. Dr. Sawant has also held senior roles at Riverbed Technology, NetApp, and TCS. He also serves as a consultant, startup advisor, and leadership mentor.
"It is such a transformative time at Somatix and for the Healthcare industry in general and I am excited to be part of the leadership team. In my last couple of roles, I focused on protecting customers' data, and now I get to play a part in protecting people's lives through remote patient monitoring," said Dr. Sawant. "Somatix, with its innovative technology, strong leadership, and laser focus strategy is poised to make a big impact in the market and in patients' lives."
"Dr. Sawant's proven track record of successfully launching products with billion-dollar revenue in existig and new markets will be critical for the next phase of Somatix's growth," said Dr. Charles Herman, Somatix's CEO. "In his role, Dr. Sawant will oversee the development and delivery of Somatix's technology solutions to its customers."
Media Contact: firstname.lastname@example.org
View original content to download multimedia:http://www.prnewswire.com/news-releases/somatix-appoints-technology-veteran-dr-amit-sawant-as-its-first-chief-business-development-officer-301293748.html
SOURCE Somatix, Inc.